BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 17517179)

  • 1. Generation of cytotoxic T lymphocytes specific for B-cell acute lymphoblastic leukemia family-shared peptides derived from immunoglobulin heavy chain framework region.
    Liu Y; Zhu P; Hu YM
    Chin Med J (Engl); 2007 Apr; 120(8):652-7. PubMed ID: 17517179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proliferation of specific cytotoxic T lymphocytes induced by immunoglobulin heavy chain framework region-derived antigenic nonapeptides].
    Liu Y; Zhu P; Hu YM
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(2):97-102. PubMed ID: 14990121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epitopes recognized by cytotoxic T lymphocytes in immunoglobulin heavy chain variable regions expressed by B-cell acute lymphoblastic leukemia].
    Liu Y; Zhu P; Hu YM
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):106-10. PubMed ID: 15946551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Function analysis of the family-specific CTL induced by peptides derived from IgHV gene framework region of B-cell malignance].
    Guo XL; Zhu P; Liu Y; Liu J; Zhu X
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):453-7. PubMed ID: 16383233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of immunoglobulin heavy chain variable region genes in childhood B-cell acute lymphoblastic leukemia].
    Liu Y; Zhu P; Hu YM
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):8-12. PubMed ID: 14990068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
    Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induction of anti-B-cell acute lymphoblastic leukemia cytotoxic T lymphocyte response against immunoglobulin heavy chain frame-derived nonapeptide].
    Liu Y; Zhu P; Hu YM
    Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):285-8. PubMed ID: 15949291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The characteristics of anti-B-cell malignance cytotoxic T lymphocytic clones induced by lymphoma relative peptides].
    Guo XL; Zhu P; Zhu X; Liu J; Ou Y; Du JW
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1476-80. PubMed ID: 16061026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of anti B-cell malignance CTL response by subfamily-shared peptides derived from variable domain of immunoglobulin heavy chain.
    Xiaoling G; Ying L; Jing L; Huifang L; Xia Z; Qingqing F; Ping Z
    Cancer Immunol Immunother; 2005 Nov; 54(11):1106-14. PubMed ID: 15889252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new subgroup of immunoglobulin heavy chain variable region genes for the assessment of clonality in feline B-cell lymphomas.
    Henrich M; Hecht W; Weiss AT; Reinacher M
    Vet Immunol Immunopathol; 2009 Jul; 130(1-2):59-69. PubMed ID: 19243841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of humoral and cellular anti-idiotypic immunity by intradermal injection of naked DNA encoding a human variable region gene sequence of an immunoglobulin heavy chain in a B cell malignancy.
    Abe A; Emi N; Taji H; Kasai M; Kohno A; Saito H
    Gene Ther; 1996 Nov; 3(11):988-93. PubMed ID: 8940639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies.
    Trojan A; Schultze JL; Witzens M; Vonderheide RH; Ladetto M; Donovan JW; Gribben JG
    Nat Med; 2000 Jun; 6(6):667-72. PubMed ID: 10835683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells.
    Gricks CS; Rawlings E; Foroni L; Madrigal JA; Amlot PL
    Cancer Res; 2001 Jul; 61(13):5145-52. PubMed ID: 11431353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies.
    Bae J; Martinson JA; Klingemann HG
    Clin Cancer Res; 2005 Feb; 11(4):1629-38. PubMed ID: 15746068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs.
    Gomi S; Nakao M; Niiya F; Imamura Y; Kawano K; Nishizaka S; Hayashi A; Sobao Y; Oizumi K; Itoh K
    J Immunol; 1999 Nov; 163(9):4994-5004. PubMed ID: 10528204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias.
    Deane M; Norton JD
    Eur J Immunol; 1990 Oct; 20(10):2209-17. PubMed ID: 1700749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.
    Hojjat-Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Mellstedt H; Shokri F; Rabbani H
    Cancer Sci; 2009 Dec; 100(12):2346-53. PubMed ID: 19824994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the horse V(H) repertoire and comparison with the human IGHV germline genes, and sheep, cattle and pig V(H) sequences.
    Almagro JC; Martinez L; Smith SL; Alagon A; Estevez J; Paniagua J
    Mol Immunol; 2006 Apr; 43(11):1836-45. PubMed ID: 16337682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].
    Gu WY; Cao XS; Qiu GQ; Chen ZX; Sheng LX; Xie XB; He J; Cen JN; Shen HL
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3475-80. PubMed ID: 16686063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.